Clinical Trial Update: Efficacy and Tolerability of Grazoprevir and Elbasvir in Patients With Chronic Genotype 1 HCV and HIV Co-infection [Phase 4]

View source ↗

Summary

A Phase 4 trial updated on the efficacy and tolerability of grazoprevir and elbasvir in patients with chronic hepatitis C and HIV co-infection.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Co-infection
• Hepatitis C

Drugs mentioned

• Grazoprevir and Elbasvir (grazoprevir and elbasvir)

Snippet

Sponsor: Taoyuan General Hospital | Conditions: Chronic Hepatitis C | Phase 4 | Status: COMPLETED